Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)

被引：27

作者：

Farmer, Luc J. ^{[1
]}

Bemis, Guy ^{[1
]}

Britt, Shawn D. ^{[1
]}

Cochran, John ^{[1
]}

Connors, Martin ^{[1
]}

Harrington, Edmund M. ^{[1
]}

Hoock, Thomas ^{[1
]}

Markland, William ^{[1
]}

Nanthakumar, Suganthini ^{[1
]}

Taslimi, Paul ^{[1
]}

Ter Haar, Ernst ^{[1
]}

Wang, Jian ^{[1
]}

Zhaveri, Darshana ^{[1
]}

Salituro, Francesco G. ^{[1
]}

机构：

[1] Vertex Pharmaceut Inc, Dept Med Chem, Cambridge, MA 02139 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 23期

关键词：

SYK; Spleen tyrosine kinase; Asthma;

D O I：

10.1016/j.bmcl.2008.09.106

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of SYK inhibitors based on the phenylamino pyrimidine thiazole lead 4 were prepared and evaluated for biological activity. Lead optimization provided compounds with nanomolar K-i's against SYK and potent inhibition in mast cell degranulation assays. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：6231 / 6235

页数：5

共 50 条

[21] Spleen Tyrosine Kinase (syk): A Novel Regulator of Neutrophil Infiltration in Hepatic Iri
Boominathan, V.
Kobayashi, A.
Duarte, S.
Zarrinpar, A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 554 - 554
[22] SPLEEN TYROSINE KINASE (SYK) - A NOVEL TARGET INVOLVED IN CFTR BIOGENESIS AND TRAFFICKING
Luz, S. F.
Mendes, A.
Romeiras, F. M.
Matos, P.
Jordan, P.
Amaral, M. D.
Farinha, C. M.
PEDIATRIC PULMONOLOGY, 2010, : 226 - 226
[23] Design and optimization of orally spleen tyrosine kinase (SYK) inhibitors for treatment of solid tumor
Wang, Cheng
Wang, Xin
Li, Yao
Wang, Tianqi
Huang, Zhi
Qin, Zhongxiang
Yang, Shengyong
Xiang, Rong
Fan, Yan
BIOORGANIC CHEMISTRY, 2020, 95
[24] Effect of Spleen Tyrosine Kinase (Syk) Inhibitors on synovial Fibroblasts of Patients with rheumatoid Arthritis
Missimana, Pierrette Lallah
Diller, Magnus
Rehart, Stefan
Mueller-Ladner, Ulf
Neumann, Elena
INTERNIST, 2019, 60 : S31 - S32
[25] Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)
Lam, Betty
Arikawa, Yasuyoshi
Cramlett, Joshua
Dong, Qing
de Jong, Ron
Feher, Victoria
Grimshaw, Charles E.
Farrell, Pamela J.
Hoffman, Isaac D.
Jennings, Andy
Jones, Benjamin
Matuszkiewicz, Jennifer
Miura, Joanne
Miyake, Hiroshi
Natala, Srinivasa Reddy
Shi, Lihong
Takahashi, Masashi
Taylor, Ewan
Wyrick, Corey
Yano, Jason
Zalevsky, Jonathan
Nie, Zhe
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (24) : 5947 - 5950
[26] Discovery of TAK-659, an orally available investigational inhibitor of spleen tyrosine kinase (SYK)
Lam, Betty
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[27] Discovery of GS-9973: A selective and orally efficacious inhibitor of spleen tyrosine kinase (Syk)
Mitchell, Scott A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[28] Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.
Crackower, M. A.
Moy, L. Y.
Jia, Y.
Yu, H.
Vincent, S.
Miller, J. R.
Lieber, G.
Fernandez, X.
Caniga, M.
Gil, M.
Wilhelm, A.
Houshyar, H.
Northrup, A.
Chapman, R.
Abraham, W. M.
Kelly, N.
Hickey, E.
Miller, T.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB49 - AB49
[29] Design and discovery of new selective and potent VEGF receptor 2 tyrosine kinase inhibitors
Hou, Fei
Yao, Yuhong
Wei, Yujiao
Wang, Yubo
Cao, Yangzi
Liu, Xinqiang
Zheng, Liting
Zhang, Qingqing
Jiao, Yue
Chen, Yukun
Meng, Yue
Sun, Yue
Wu, Yanjie
Wang, Jiefu
Wang, Junfeng
Wu, Zhou
Zhang, Kun
Wei, Mingming
Yang, Guang
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 91
[30] Carboxamide Spleen Tyrosine Kinase (Syk) Inhibitors: Leveraging Ground State Interactions To Accelerate Optimization
Ellis, J. Michael
Altman, Michael D.
Cash, Brandon
Haidle, Andrew M.
Kubiak, Rachel L.
Maddess, Matthew L.
Yan, Youwei
Northrup, Alan B.
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (12): : 1151 - 1155

← 1 2 3 4 5 →